Pulmonary metastases: can accurate radiological evaluation avoid thoracotomic approach?
Objectives: To evaluate the effectiveness of radiological assessment (high-resolution CT (HRCT),
helical CT (HCT) scan) of lung metastases and to verify if a complete manual …
helical CT (HCT) scan) of lung metastases and to verify if a complete manual …
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease
…, P Cattani, E Martinelli, A Motta, G Macis… - Current topics in …, 2016 - ingentaconnect.com
Breathomics, the multidimensional molecular analysis of exhaled breath, includes analysis
of exhaled breath with gas-chromatography/mass spectrometry (GC/MS) and electronic …
of exhaled breath with gas-chromatography/mass spectrometry (GC/MS) and electronic …
Dupilumab for the treatment of asthma
…, C Mondino, R Anzivino, G Macis… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Dupilumab (REGN668/SAR231893), produced by a collaboration between
Regeneron and Sanofi, is a monoclonal antibody currently in phase III for moderate-to-severe …
Regeneron and Sanofi, is a monoclonal antibody currently in phase III for moderate-to-severe …
Triple inhaled therapy for chronic obstructive pulmonary disease
P Montuschi, M Malerba, G Macis, N Mores… - Drug discovery today, 2016 - Elsevier
Highlights • Triple therapy in a single inhaler is a new therapeutic option for COPD. • Three
fixed dose combinations of inhaled corticosteroids LABA and LAMA are in Phase III of clinical …
fixed dose combinations of inhaled corticosteroids LABA and LAMA are in Phase III of clinical …
[HTML][HTML] Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA–IIIB) non-small-cell lung cancer: long-term results according to downstaging
…, P Granone, S Valente, S Margaritora, G Macis… - Annals of oncology, 2004 - Elsevier
Background To report the efficacy of induction treatment (IT) protocol with concurrent
radiochemotherapy in locally advanced non-small-cell lung cancer (NSCLC), and to analyze …
radiochemotherapy in locally advanced non-small-cell lung cancer (NSCLC), and to analyze …
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients
…, F Colella, N Mores, G Macis… - European …, 2021 - Eur Respiratory Soc
Extracellular vesicles, nano-sized (20–1000 nm) membranous structures released from cells,
play critical roles in both physiological and pathological processes [1]. Extracellular …
play critical roles in both physiological and pathological processes [1]. Extracellular …
NMR-based metabolomics for the assessment of inhaled pharmacotherapy in chronic obstructive pulmonary disease patients
The aim of this proof-of-concept, pilot study was the evaluation of the effects of steroid
administration and suspension of an inhaled corticosteroid (ICS)-long-acting β 2 -agonist (LABA) …
administration and suspension of an inhaled corticosteroid (ICS)-long-acting β 2 -agonist (LABA) …
Investigational prostaglandin D2 receptor antagonists for airway inflammation
…, N Mores, M Malerba, C Mondino, G Macis… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: By activating DP 1 and DP 2 receptors on immune and non-immune cells,
prostaglandin D 2 (PGD 2 ), a major metabolic product of cyclo-oxygenase pathway released …
prostaglandin D 2 (PGD 2 ), a major metabolic product of cyclo-oxygenase pathway released …
[PDF][PDF] Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non–small-cell lung cancer
…, P Granone, S Valente, A Turriziani, G Macis… - Journal of clinical …, 2002 - academia.edu
Purpose: To report the evidence of a phase I trial planned to determine the maximum-tolerated
dose (MTD) and related toxicity of weekly gemcitabine (GEM) and concurrent …
dose (MTD) and related toxicity of weekly gemcitabine (GEM) and concurrent …
Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach
…, A Cesario, S Margaritora, V Porziella, G Macis… - The Annals of thoracic …, 2003 - Elsevier
BACKGROUND: Stage IIIb (T4/N3) non–small-cell lung cancer (NSCLC) is considered an
inoperable disease and treatment is an enduring challenge. Surgery after induction therapy …
inoperable disease and treatment is an enduring challenge. Surgery after induction therapy …